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Abstract
The chapter aims at providing readers with the overview of the herpesvirus infection
in  bovines.  It  includes  the  detailed  etiology  of  the  infection,  discussing  the  virus
characteristics, virus structure, genome, viral proteins, types and subtypes of the virus.
Then, the chapter discusses the transmission and pathogenesis of the virus, which are
very important as they help to control the virus spread, viral latency and clinical signs
observed  in  the  affected  animals.  Later,  the  chapter  discusses  the  diagnosis  of
herpesvirus  infection in  bovines  to  help the readers  to  gain knowledge about  the
techniques used earlier and nowadays for the diagnosis of the infection. Then, the
chapter provides information on the procedures to be adopted for the prevention and
control of the infection in bovines. Thus, the chapter provides complete information
about the herpesvirus infection in bovines.
Keywords: bovines, herpesvirus, etiology, epidemiology, diagnosis, prevention, con‐
trol
1. Introduction
Viruses have either RNA or DNA as their genome which is one of the criteria for the classifica‐
tion of viruses. Among the DNA virus families is the Herpesviridae family. It is the largest DNA
family and derives its name from the Greek word, “herpein”, which means “to creep”. The
viruses belonging to this family affect a number of species of mammals, birds, reptiles, fishes
and amphibians. This chapter discusses the herpesvirus infection in bovines.
There are many bovine herpesviruses belonging to different genus viz. Bovine herpesvirus-1
(BHV-1), BHV-2, BHV-4, BHV-5 in the family Herpesviridae. BHV-2 causes skin lesions, BHV-4
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often produces subclinical infection and BHV-5 produces meningoencephalitis. This chapter
is written with an aim to focus on the most important disease caused by herpesviruses in
bovines; infectious bovine rhinotracheitis caused by BHV-1.
BHV-1 is one of the important viruses responsible for great economic loss to the livestock
industry. It causes losses in terms of drop in milk yield, abortion and repeat breeding. BHV-1
is associated with different clinical conditions like respiratory infections, conjunctivitis,
vulvovaginitis, abortion and balanoposthitis in males. It is also associated with encephalitis
and generalized systemic infections [1] too. The virus is readily transmitted and has world‐
wide distribution. The virus can remain latent in the ganglia of the infected, but clinically
normal, animals [2]. The virus is excreted through nasal and ocular secretions, placenta of
aborted animals and through semen. The virus transmission via semen is special concern to
cattle breeders.
Mayfield et al. [3] identified 3 strains of BHV-1 namely I, II, III depending on the restriction
pattern. Studdert [4] reclassified them as BHV-1.1 (respiratory form), BHV-1.2 (genital form)
and BHV-1.3 (encephalitic form). BHV-1 consists of 25–33 polypeptides of which 11 are
glycosylated [5–7] and associated with virus envelope [5, 6]. The three sets of enveloped
glycoproteins gI, gIII and gIV were characterized earlier which are involved in the immune
response [7–12]. Babiuk et al. [13] showed that gIV produces the highest serum-neutralizing
antibody titres with gI being the least immunogenic. The strains of BHV-1 with different tissue
affinities may exist in the field conditions and these different clinical strains can be differen‐
tiated by restriction endonuclease strategies [14]. The monoclonal antibodies specific for the
major BHV-1 glycoproteins GVP6/11a/16, GVP7, GVP3/9 and GVP11/b are used to deter‐
mine the glycoproteins and identify the epitopes involved in neutralization and antibody
complement lysis [15]. Both humoral and cell-mediated immune responses are generated
against BHV-1, but cell-mediated immune response is the major means of defence mecha‐
nisms [16]. The disease can be diagnosed by clinical signs and lesions and by a variety of
virologic and immunologic techniques [17].
This chapter is written with an aim to provide information on herpesvirus in bovines to the
readers.
2. Taxonomy and nomenclature
In 1973, the International Committee for the Taxonomy of Viruses (ICTV) named the virus as
bovid herpesvirus type-1 [18] on the basis of the family of virus and the host it infects. The
nomenclature system was further discussed in the International Committee for the Taxono‐
my of Herpesvirus (ICTH) in 1976 [19]. Then, Gibbs and Rweyemamu [1] adopted a system
based on sub-family of Bovidae and named the virus to be BHV-1.
According to ICTV, the Herpesviridae family includes three subfamilies. The three subfami‐
lies are Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae. Alphaherpesvirus‐
es replicate and spread in the host, rapidly destroying the host cells. They establish the latent
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infection in the sensory ganglia of the host. Betaherpesviruses replicate and spread in the host
slowly. They cause infected cells to enlarge, hence they are commonly named as cytomegalo‐
viruses. They become latent in secretory glands and lymphoreticular cells of the host.
Gammaherpesviruses infect T and B lymphocytes of the host and produce latent infections in
these cells. Some of Gammaherpesviruses also replicate in epithelial and fibroblastic cells
causing cytolysis. Many of these viruses lead to neoplastic transformation of lymphocytes.
There are nine genera included in the family Herpesviridae. The genera included in the
subfamily Alphaherpesvirinae are Simplexvirus (includes BHV-2), Varicellovirus (includes
BHV-1 and BHV-5), Mardivirus and Iltovirus. The genera included in the subfamily
Betaherpesvirinae are Cytomegalovirus, Muromegalovirus and Roseolovirus. The genera
included in the subfamily Gammaherpesvirinae are Lymphocryptovirus and Rhadinovirus
(includes BHV-4). There is a 10th genera including Ictalurid herpes-like viruses which includes
herpesviruses of fish. BHV-1 is also known as infectious bovine rhinotracheitis virus; BHV-5
is also known as bovine encephalitis virus and BHV-4 is also known as Movar virus. There is
a proposal in ICTV to create the BHV-6 in the new genus Macavirus in the subfamily
Gammaherpesvirinae.
Herpesviruses of mammals, birds and reptiles share extensive genetic relationship among
themselves. Herpesviruses of fish and amphibians are also related to each other but are related
only marginally to herpesviruses of mammals, birds and reptiles. No herpesvirus-specific gene
is conserved between the classes, but one gene which encodes the putative ATPase subunit of
a DNA-packaging terminase is conserved among all herpesviruses.
3. Virus structure and genome
BHV-1 has icosahedral symmetry approximately 150–200 nm in diameter [1, 20]. The struc‐
ture of the virus consists of four parts viz.
1. The core which includes the genome having linear double-stranded DNA molecule of 139
Kbp [21, 22] in the form of a torus. The G+C content of the genome ranges from 31 to 75%
and contains 60 to 120 genes [23]. Herpesvirus genes are not arranged in operons and in
most cases have individual promoters. The genome termini are not covalently closed or
covalently linked to a protein. All herpesvirus genomes contain lengthy terminal repeats,
both direct and inverted.
2. The core is surrounded by the icosahedral capsid made up of 162 capsomeres.
3. The virus consists of an envelope which forms the outer layer of virion. The lipid bilayer
envelope is derived from the nuclear membrane of the host by budding [24, 25]. It consists
of unique viral glycoproteins which appear as short spikes embedded in the envelope.
4. Between the capsid and the envelope is a proteinaceous layer known as tegument. It
consists of the viral enzymes needed to take control of host cell chemical processes for
virion production and also to defend itself from the host cell responses.
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The glycoproteins are critical to the virus for attachment to [26] and penetration of the
susceptible cells [27] and to the host for virus neutralization [28] by the production of
neutralizing antibodies. The glycoproteins are the major targets of immune response both at
humoral and cellular level [29]. The major BHV-1 proteins that are involved in the immune
response are gI, gIII and gIV enveloped glycoproteins [11].
Replication of herpesvirus occurs in the nucleus of the host cell and the envelope is derived
from the nuclear membrane of the host cell. The virions are released by exocytosis. Intranu‐
clear inclusion bodies are formed, which are the characteristic of herpesviruses. Herpesvirus
genomes replicate by circularization and production of concatemers, followed by cleavage of
unit-length genomes during packaging into capsids [30].
For the replication to initiate, the virion attaches to host cell (heparan sulfate moieties of cellular
proteoglycans) with the envelope glycoprotein, gC. The viral envelope fuses to the plasma
membrane of the host cell so that the nucleocapsid enters the cytoplasm. The glycoproteins
involved during this process are gB, gD and gH. The capsid travels along the cytoskeleton to
a nuclear pore where the viral DNA is released. The linear genome enters the nucleus and
circularizes. Once in the nucleus, the viral DNA is transcribed into mRNA by cellular RNA
polymerase II. The viral gene expression is tightly regulated. First, the tegument protein
associates with two cellular proteins and the complex transactivates transcription of immedi‐
ate-early (IE or alpha) genes. The immediate-early genes encode regulatory proteins and
initiates transcription of the early (E or beta) genes. These proteins are enzymes needed for
viral replication. Then, the late (L or gamma) genes are activated for production of viral
structural proteins. After transcription in the nucleus, all mRNA transcripts are translated into
protein in the cytoplasm. Subsequently, the proteins can go to the nucleus, stay in the
cytoplasm, or become a part of the membrane bilayer. Capsid proteins assemble in the nucleus
to form empty capsids. In these capsids, full-length viral DNA is packaged to form nucleo‐
capsids. The nucleocapsids associate with segments of the nuclear membrane where tegu‐
ment and glycosylated envelope proteins have bound. This association triggers the formation
of envelope by budding through the nuclear membrane. Enveloped virions accumulate in the
endoplasmic reticulum. Mature virions are released by exocytosis.
4. Physico-chemical and antigenic properties of BHV-1
The virus is sensitive to ether, chloroform, acetone, alcohol and bile salts. It is inactivated
within 10 min at 56°C and in 4 min at 65°C. The virus is labile at pH 4.5 to 5.0, but stable between
pH 6 to 9. Virus is extremely susceptible to 0.5% sodium hydroxide, 0.01% HgCl2, 1% phenol
and 1% quaternary ammonium compounds. Also, 5% formalin can inactivate the virus in 1
min. Thus, the virus is fragile and sensitive to detergents and lipid solvents. It is unstable in
the environment, but can survive in the frozen semen indefinitely.
Antigenically, there is only a single serotype of BHV-1 recognized. There are three strains of
BHV-1 (I, II, III) described on the basis of endonuclease pattern of viral DNA [3]. Studdert [4]
reclassified them as BHV-1.1 (respiratory subtype), BHV-1.2 (genital subtype) and BHV-1.3
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(encephalitic subtype). BHV-1.3 has been reclassified as a distinct herpesvirus designated as
BHV-5. BHV-1 is antigenically related to equine rhinopneumonitis virus (EHV-1) in comple‐
ment fixation test [31]. It also shares one-way relationship with Pseudorabies virus and goat
herpesvirus [32]. The virus also shares a common antigen with Marek’s disease virus [33] and
Burkitts lymphoma virus.
5. Epidemiology and pathogenesis
The virus is host-specific. All ages and breeds of cattle are susceptible. Although cattle is the
natural host for infectious bovine rhinotracheitis infection, antibodies against BHV-1 have also
been demonstrated in sheep, goat, pigs and wild animals [34]. The disease mostly occurs in
animals over 6 months of age. Prevalence of BHV-1 increases with age and is less prevalent in
cows under 2 years of age. The virus does not discriminate between sex and breed; however,
feed lot cattle are more frequently infected than dairy cattle [35].
The virus is readily transmitted and has worldwide distribution. Transmission of the virus
occurs by aerosol route. The virus is also secreted through nasal and ocular secretions, genital
secretions and placenta of aborted animals and also in milk [1]. The virus is also transmitted
through infected semen during artificial insemination and embryo transfer. It is the most
common viral pathogen found in bovine semen [36]. The extensive use of artificial insemina‐
tion in cattle has facilitated the exchange of genetic characteristics. Therefore, contamination
of semen and dissemination of bovine pathogens via semen are of primary concern to cattle
breeders. It also poses a potential threat to cattle industry as it can cause a variety of genital
tract disorders including endometritis, infertility and abortion [37]. Thus, semen should ideally
be collected from bulls that are serologically negative for BHV-1 infection. After primary
respiratory or genital infections, animals become lifelong carriers of BHV-1, despite the
development of neutralizing antibodies. Reactivation of latent BHV-1 in carrier animals occurs
periodically and has been due to stress such as intercurrent diseases, transportation, cold,
crowding and corticosteroid treatment.
Pathogenesis depends upon the subtype of virus and route of entry of the virus. If the virus
(BHV-1.1) enters by aerosol route, it replicates in the mucous membrane of the upper
respiratory tract. Thus, the virus is shed in nasal secretions. The virus enters local nerve cell
endings and becomes latent in trigeminal ganglion. Secondary bacterial infection leads to
systemic infection and death of the animal. Abortion occurs due to fetal infection. Genital
infection is caused by subtype BHV-1.2. In this case, the virus replicates in the mucosa of vagina
or prepuce and becomes latent in sacral ganglion. Focal necrotic lesions occur on genital
mucosa, which later on forms ulcers. Abortion does not occur in the animals affected by
BHV-1.2.




Infectious bovine rhinotracheitis initially had several names such as “red nose”, “dust
pneumonia”, “necrotic rhinitis” or “necrotic rhinotracheitis” based on the signs and symp‐
toms manifested by the virus in different parts of the world [38]. The reproductive form of the
disease was reported as early as 1938 and was called “epivag”, which means causing epidi‐
dymitis in males. In 1955, at a meeting of US Livestock Sanitary Association it was designat‐
ed as infectious bovine rhinotracheitis (IBR) [39].
BHV-1 causes various clinical manifestations in cattle and buffaloes. Type of disease caused
by the virus depends mostly on the route of the entry of virus. The incubation period of the
disease is 2 to 4 days. In case of the respiratory form of infection, the virus multiplies initial‐
ly in the tissues of respiratory tract and is extended via the lacrimal ducts to the ocular tissues
where a secondary site of infection is established. There is sudden onset of anorexia, fever,
severe hyperaemia of the nasal mucosa, serous discharge from the eyes and nose, increased
salivation and excitation. There is sharp drop in milk yield. Animal has respiratory distress
and sudden death occurs within 24 hours after the first signs appear due to obstructive
bronchitis. In prolonged cases, the nasal discharge becomes profuse and purulent and death
occurs due to secondary bronchopneumonia. There is either bilateral or unilateral conjuncti‐
vitis or keratoconjunctivitis with profuse lacrimation. Various workers [40, 41] have isolated
IBR virus from the conjunctival and nasal discharge of calves showing symptoms of the
disease. The BHV-1 type causing respiratory form of the disease causes abortions usually
during 4–8 months of gestation. Abortion occurs due to fetal infection which results in severe
visceral damage, gradual cessation of placental circulation and placental degeneration, leading
to detachment and abortion.
Kendrick et al. [42] isolated herpesvirus from genital infection of cows which they termed as
infectious pustular vulvo-vaginitis (IPV) caused by the genital form (BHV-1.2) of the virus.
The initial signs in the genital form of the disease include reddening of the vaginal mucosa
and pustule formation, which lead to mucopurulent vaginal discharge. No abortion is seen in
this form of the disease. The respiratory and genital forms of the disease are rarely seen at the
same time in a herd. Bouters et al. [43] isolated herpesvirus from bulls with infectious pustular
balanoposthitis and orchitis. Thus, in males, there is inflammation of preputial lining with
pustule formation. Singh et al. [44] isolated IBR/IPV virus from the semen of Jersey bull and
from the placenta and cotyledons of Jersey cow.
7. Diagnosis
Any disease control programme has a prerequisite of diagnosis at the earliest. The serologi‐
cal assays for antibodies to BHV-1 have been widely used for the diagnosis of acute infec‐
tions, epidemiological studies and the detection of latent carriers in relation to control schemes
and international trade. Gibbs and Rweyemamu [1] reviewed the diagnostic tests available for
BHV-1. These included the conventional clinical diagnosis based on signs and symptoms; but
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as the virus has numerous clinical manifestations, diagnosis is difficult and requires labora‐
tory confirmation. So, the specific diagnosis of IBR has been traditionally based on the isolation
of the causal agent in the cell culture, together with the detection of active antibody re‐
sponse in the host animal. In the cell culture system, the detection of IBR virus is based on the
cytopathic effects (CPE) characterized by rounding of individual cells with shrinkage of some
with increased granularity, which progresses rapidly to a characteristic “bunch of grapes”.
The detection of viral antigen in clinical samples like nasal swabs, conjunctival swabs, vaginal
discharge, semen, preputial washings, placenta and aborted fetus can be rapid and economi‐
cal alternative to cell culture. The most widely applied antigen detection technique has been
immunofluorescence, either on smears of cells from nasal or ocular epithelium [45] or on
cryostat sections of tissues collected at post-mortem. Electron microscopy is another rapid,
reliable method of diagnosis of the antigen, but it is difficult to distinguish all herpesviruses
[1]. Immunoenzymatic techniques have been described for the labeling of infected cells [46]
and for the detection of soluble antigen in diluted nasal mucus [9]. The fluorescent antibody
technique (FAT) is frequently used to diagnose respiratory and reproductive forms of BHV-1
infections. Frank et al. [47] described FAT as the test of choice for diagnosis of IBR/IPV virus.
The virus can also be identified by neutralization test with mono-specific antiserum or with
the use of monoclonal antibodies. Monoclonal antibodies can differentiate between BHV-1
subtypes like BHV-1.1 and BHV-1.2 [20]. Further characterization can be done by DNA
restriction enzyme analysis. Enzyme-linked immunosorbent assay (ELISA) to capture antigen
can also be done.
The serological investigations are the faster means of detecting the prevalence of antibody in
cattle population. The virus neutralization test is highly specific and reliable for the detec‐
tion of BHV-1 antibodies. The other serological techniques used for the detection of antibod‐
ies include passive hemagglutination test, indirect hemagglutination test, agar gel diffusion
test (AGID), counter immunoelectrophoresis and complement fixation test (CFT). ELISAs for
antibody detection are also being used frequently. Payment et al. [48] compared serum
neutralization test (SNT) with ELISA and reported that the antibody titres detected were 100
times higher than those seen in SNT, which showed the increased sensitivity of enzyme
immunoassay. The rapid diagnosis of recent infection to BHV-1 was carried out using ELISA
by detecting virus-specific IgM by Edwards et al. [49]. Edwards and Gitao [50] reported that
antigen detection using avidin-biotin ELISA increased by 50-fold than compared to simple
sandwich ELISA. Renukaradhya et al. [51] and Suresh et al. [52] demonstrated the use of
avidin-biotin ELISA for the epidemiological studies against IBR antibodies. A gE ELISA is
based on the use of two different monoclonal antibodies against gE of BHV-1. Thus, this ELISA
detects antibodies against two different epitopes on gE [53]. The gE ELISA can detect anti‐
bodies in milk and in bulk milk samples [54]. The milk samples tested by ELISA have
advantages over the SNT for mass field surveys [55]. Perrin et al. [56] reported that paired
sample of serum and milk indicated that IBR antibody concentration in serum was about 200
times higher than in milk; hence, negative ELISA results in bulk milk samples would not
exclude the possibility of infection in up to 25% animals. Since the antibody concentration in
the milk is lower than serum, the antibody in the milk should be concentrated by the addi‐
tion of rennet and ammonium sulfate and the ELISA should be carried out to a solution of the
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precipitate. To differentiate between the vaccinated and naturally infected animals (DIVA
strategy), gE blocking ELISA can be used [54].
Isolation of the IBR virus was done for the first time by Madin et al. [57]. Their earlier attempts
to recover the virus in chicken embryo, in weaning and suckling mice and in guinea pigs were
unsuccessful. The failure was followed by successful isolation of the virus in tissue cultures of
bovine embryonic kidney. Mehrotra et al. [58] isolated the virus in primary calf kidney cell
culture and the virus produced intranuclear inclusions and CPE. The virus was also isolated
from semen, placenta and cotyledons employing bovine embryonic kidney and bovine
turbinate cell lines [44]. Mehrotra et al. [59] isolated BHV-1 in primary cow calf kidney (PCCK)
cell culture and used Madin Darby bovine kidney (MDBK) cell line for subsequent passages
and characterization of virus isolate. BHV-1 was isolated from the conjunctiva of affected cow
after serial passages in MDBK cell line by Mohan Kumar et al. [60].
Nucleic acid detection methods also have widespread application in routine diagnosis
nowadays and they have the advantage of being sensitive and quicker than virus isolation.
Engelenburg et al. [61] developed polymerase chain reaction (PCR) assay to detect BHV-1 in
bovine semen using a purification method to eliminate interfering components. The results of
PCR were achieved in a day compared with virus isolation, which takes 7 days and is less
laborious. Wiedmann et al. [62] used a nested PCR assay targeting a portion of the glycopro‐
tein IV gene to detect BHV-1 DNA. Kibenge et al. [63] amplified strains of BHV-1 by PCR with
primers in the thymidine kinase gene region. Vilcek et al. [64] employed PCR assay on samples
like nasal swabs, lung, lymph nodes and tracheal mucosa. Masri et al. [65] used a rapid nested
PCR for detection of BHV-1 in semen of infected bulls in which dexamethasone was given for
reactivation of BHV-1 from latency. Santurde et al. [66] detected BHV-1 using PCR amplifica‐
tion of a highly conserved DNA fragment within the glycoprotein gI sequence (323 bp between
nucleotide 1491 to nucleotide 1814) of the virus. Ashbaugh et al. [67] used nested PCR for
simultaneously detecting and discriminating between BHV-1 and BHV-5 using type-com‐
mon primers derived from gC sequences. Nested PCR is more sensitive than PCR. Rocha et
al. [68] detected BHV-1 in the tissues of a naturally aborted bovine fetus by nested PCR assay.
Further, real-time PCR can be used for detection and characterization of BHV-1 virus. The real-
time PCR reveals the results in the real time during the time the PCR is running. It is a highly
sensitive, specific and reliable assay.
The authors developed monoclonal antibodies against BHV-1 [69] using hybridoma technol‐
ogy. The technology is detailed below:
7.1. Propagation of virus in MDBK cell culture
The virus BHV-1 isolate was propagated in MDBK cell line using Dulbecco’s minimum
essential medium with 10 and 2% FCS for growth and maintenance, respectively, for prepar‐
ing antigen in bulk quantity.
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7.2. Purification of the virus
The cell culture fluid, after three cycles of freezing and thawing, was centrifuged at 7000 rpm
for 20 min at 4°C to collect supernatant. The supernatant was subjected to ultracentrifuga‐
tion at 105 × g for 1 hour to pellet the virus. The pellet was resuspended in 500 μl of phos‐
phate buffered saline and subjected to 20–40% (w/v) sucrose density gradient centrifugation
(the sucrose gradient was prepared in 200 mM tris 50 mM NaCl buffer, pH 8.0) at 105 × g for
2 hours and 30 min to collect the virus at the junction of 20–40% sucrose. The presence of virus
was confirmed by agar gel precipitation test (AGPT) as per Le Yeune et al. [70] and the protein
content was estimated [71].
7.3. Immunization of BALB/C mice
BALB/C mice of 6–7 weeks of age procured from the National Institute of Nutrition,
Hyderabad, India, were used for immunization. Four hundred microgram of purified virus
was mixed with equal amount of Freund’s complete adjuvant to prepare an emulsion and
injected into mice via intraperitoneal route. Booster was administered after 14 days with 100
μg of purified virus alone via intraperitoneal route. Three days after the second injection, all
the mice were tail bled to collect serum which was subjected to ELISA to determine the antiviral
antibodies. For this, the ELISA plate was coated with purified virus (10μg/ml) and incubated
overnight at 4°C. About 100 μl of each dilution (1:20 and 1:40) of the test serum was added in
duplicate wells and the normal serum served as negative control. The plates were incubated
at 37°C for 2 hours. After washing the plate three times, 100 μl of anti-mouse IgG-horse radish
peroxidase conjugate (1:10,000) was added in each well and further incubated the plate at
37°C for 2 hours. After washing, 100 μl of substrate solution was added to each well and
incubated the plate at room temperature for 10 min. After stopping the reaction with 50 μl
of 1M H2SO4, optical density was read at 450 nm wavelength.
7.4. Myeloma cell line
Non-secretory myeloma cell line SP2/O/Ag-14, procured from the National Centre for Cell
Science, Pune, India, was subcultured and maintained in RPMI-1640 medium with 10% fetal
calf serum containing 0.2% streptopenicillin (500×) and 1% glutamine. A day prior to fusion,
myeloma cells were subcultured in growth medium containing 2% 8-azaguanine. Myeloma
cells growing in log phase of growth were used for fusion.
7.5. Preparation of feeder spleen cell layer
Albino mice procured from Punjab Veterinary Vaccine Institute, Punjab Agricultural
University, Ludhiana, India, were used for the preparation of feeder layer. One day prior to
fusion, splenocyte feeder cell layer was laid down in the 24 well tissue culture plate in HAT
medium having 106 cells/ml/well. The plates were incubated in a humid incubator at 37°C
with 5% CO2 tension.
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7.6. Preparation of polyethylene glycol (PEG)
PEG (molecular weight 3000–4000) was autoclaved and immediately suspended in RPMI-1640
medium aseptically by keeping the vial at 56°C in water bath.
7.7. Fusion protocol
Myeloma cells in log phase of growth were brought into suspension by tapping and the
suspension was transferred into calibrated centrifuge tube and final volume made to 10 ml
with serum-free media. The immunized BALB/C mouse was etherized and disinfected by
dipping into 70% alcohol. The spleen was removed into a petri plate and washed with 2 ml of
serum-free media twice. The splenocytes were released into the medium by flushing with the
medium into the spleen and the cells were collected by centrifugation. The splenocytes and
myeloma cells were separately centrifuged at 4000 rpm for 10 min. The supernatant was
discarded and pellet was brought into suspension by tapping. Equal number (107) of spleen
cells and myeloma cells were mixed and co-pelleted by centrifugation at 4000 rpm for 10 min.
To the pellet, 1 ml of PEG was added slowly along the side of tube over 1 min, taking care to
swirl the tube gently while adding PEG so as to ensure proper mixing of PEG solution. The
tube was incubated at room temperature for 1 min to facilitate fusion of myeloma and
lymphocyte cells. Later, PEG was diluted by adding 10 ml of growth medium over 10 min and
centrifuged at 4000 rpm for 3min. After discarding the medium, the final pellet was dis‐
solved in 48 ml of HAT medium, and the cell suspension was dispensed in a quantity of 1 ml
in two 24 well plates, which had already been seeded with normal mice spleen feeder cells a
day before. The plates were incubated at 37° C in 5% CO2 tension. The plates were left
undisturbed for 3–4 days and examined daily for signs of growth. When the hybrids started
showing growth, the supernatants were collected aseptically and screened for anti-BHV-1
antibody secretion by indirect plate ELISA [72].
7.8. Cloning
After identification of single clone (B6.1), the cells were dislodged and ten-fold serial dilu‐
tions were made starting from 10−1 to 10−6 and dispensed in 1 ml quantity into each well which
had feeder layer one day before seeding.
7.9. Isotyping of antibodies
Isotyping of monoclonal antibodies in cell culture supernatants was performed with the
indirect ELISA-based isotyping kit.
7.10. Immunoblotting
The specificity of the monoclonal antibody for a particular protein of BHV-1 was deter‐
mined by immunoblot. For this, discontinuous system of polyacrylamide gel electrophoresis
(PAGE) [73] was followed. Electrophoresis on 10% resolving gel with 4% stacking gel in tris
glycine buffer was carried out at 140 volts for 3 to 4 hours. Following electrophoresis, the
protein was blotted to nitrocellulose membrane (NCM) in transfer buffer. Transfer of pro‐
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tein was carried out in transblot apparatus at 100 volts for 1 hour. A total of 600 ml of infected
cell culture fluid was used for purification of virus.
The importance of monoclonal antibodies lies in the fact that they are the antibodies that can
be used to detect the single epitope (protein) of the virus. Thus, they can be used in different
assays like ELISA, immunofluorescence, virus neutralization test, AGID, CFT for detecting the
virus along with differentiating between the different types of the virus. This can be ach‐
ieved by producing the monoclonal antibodies against the protein of the virus which differ‐
entiates between the types of the virus.
8. Prevention and control
Prevention and control of BHV-1 are based on intensive farm management which includes
following hygienic measures at the farm, vaccinating the animals at the right time and
detection and removal of infected animals. The practice should be made at the farm to keep
the newly introduced cattle in quarantine for the period of 4 weeks and the cattle that are
BHV-1 sero-negative should be introduced to a herd. The practice of natural mating should be
avoided and artificial insemination should be done using semen from BHV-1 negative bulls.
Eradication programmes should be followed. These include test and removal programs in
which the infected animals should be detected and culled. Carrier cattle should also be
identified and removed from the herd.
Vaccines usually prevent the development of clinical signs and markedly reduce the shed‐
ding of virus after infection, but do not completely prevent infection. Vaccination campaigns
should be a part of eradication programmes. Since BHV-1 is a highly contagious virus,
vaccination is recommended as soon as passive immunity in calves disappears, usually
around 4–6 months of age. Currently available vaccines for IBR include modified-live-virus
vaccines and inactivated vaccines. The timing of vaccination is also as important as the choice
of vaccine. Since maximum protection does not generally occur until approximately 3 weeks
after vaccination, calves should be vaccinated 2–3 weeks before weaning at which time they
start to be at risk of infection. Single vaccination will reduce the severity of disease, but not
provide complete protection. Thus, booster vaccination should be done. The use of marker
vaccines can help to distinguish between vaccinated and naturally infected animals.
9. Conclusions
The chapter concludes that the BHV type 1 is an important virus of cattle and buffaloes. As
the virus can survive for long in frozen semen, it should be of special concern during artificial
insemination and also during national and international trade.
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